The title complexes [CoⅢ(TPA)(N3)2](ClO4) 1 and [CuⅡ(TPA)(N3)](ClO4) 2 have been synthesized and characterized by single-crystal X-ray diffraction. The crystal of 1 is of monoclinic, space group P21/n with a = 10.73...The title complexes [CoⅢ(TPA)(N3)2](ClO4) 1 and [CuⅡ(TPA)(N3)](ClO4) 2 have been synthesized and characterized by single-crystal X-ray diffraction. The crystal of 1 is of monoclinic, space group P21/n with a = 10.734(3), b = 13.112(4), c = 15.327(4) , = 93.023(6), V = 2154.2(11) ?, Mr = 532.80, Z = 4, Dc = 1.643 g/cm3, m(MoKa) = 0.71073 ? F(000) = 1088, R = 0.0502 and wR = 0.0928. The CoⅢ atom is coordinated by one chelating TPA ligand and two terminal azide groups to form a distorted octahedral geometry. The crystal of 2 belongs to monoclinic, space group P21/c with a = 15.405(6), b = 9.269(4), c = 14.998(6) 3, = 93.489(7), V = 2137.6(14) ? Mr = 495.38, Z = 4, Dc = 1.539 g/cm3, m(MoKa ) = 0.71073 ? F(000) = 1012, R = 0.0521 and wR = 0.0992. The CuⅡ atom is coordinated by one chelating TPA ligand and one terminal azide group, forming a distorted trigonal bipyramidal geometry.展开更多
基金Supported by the National Natural Science Foundation of China (No. 20171026) and Natural Science Foundation of Tianjin (No. 013605811)
文摘The title complexes [CoⅢ(TPA)(N3)2](ClO4) 1 and [CuⅡ(TPA)(N3)](ClO4) 2 have been synthesized and characterized by single-crystal X-ray diffraction. The crystal of 1 is of monoclinic, space group P21/n with a = 10.734(3), b = 13.112(4), c = 15.327(4) , = 93.023(6), V = 2154.2(11) ?, Mr = 532.80, Z = 4, Dc = 1.643 g/cm3, m(MoKa) = 0.71073 ? F(000) = 1088, R = 0.0502 and wR = 0.0928. The CoⅢ atom is coordinated by one chelating TPA ligand and two terminal azide groups to form a distorted octahedral geometry. The crystal of 2 belongs to monoclinic, space group P21/c with a = 15.405(6), b = 9.269(4), c = 14.998(6) 3, = 93.489(7), V = 2137.6(14) ? Mr = 495.38, Z = 4, Dc = 1.539 g/cm3, m(MoKa ) = 0.71073 ? F(000) = 1012, R = 0.0521 and wR = 0.0992. The CuⅡ atom is coordinated by one chelating TPA ligand and one terminal azide group, forming a distorted trigonal bipyramidal geometry.